158 related articles for article (PubMed ID: 10190728)
21. Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis.
Langholm LL; Manon-Jensen T; Karsdal MA; Bendtsen F; Leeming DJ; Møller S
Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):1040-1048. PubMed ID: 30768435
[TBL] [Abstract][Full Text] [Related]
22. Serum and urinary nitrate levels in liver cirrhosis: endotoxemia, renal function and hyperdynamic circulation.
Campillo B; Bories PN; Benvenuti C; Dupeyron C
J Hepatol; 1996 Nov; 25(5):707-14. PubMed ID: 8938549
[TBL] [Abstract][Full Text] [Related]
23. Plasmatic nitric oxide, but not von Willebrand Factor, is an early marker of endothelial damage, in type 1 diabetes mellitus patients without microvascular complications.
Correa RC; Alfieri AB
J Diabetes Complications; 2003; 17(5):264-8. PubMed ID: 12954155
[TBL] [Abstract][Full Text] [Related]
24. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Freestone B; Chong AY; Nuttall S; Lip GY
Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
[TBL] [Abstract][Full Text] [Related]
25. Homocysteine and endothelial markers are increased in patients with chronic liver diseases.
Remková A; Remko M
Eur J Intern Med; 2009 Sep; 20(5):482-6. PubMed ID: 19712849
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide metabolites in decompensated liver cirrhosis.
Barak N; Zemel R; Ben-Ari Z; Braun M; Tur-Kaspa R
Dig Dis Sci; 1999 Jul; 44(7):1338-41. PubMed ID: 10489915
[TBL] [Abstract][Full Text] [Related]
27. Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients.
Ouviña SM; La Greca RD; Zanaro NL; Palmer L; Sassetti B
Thromb Res; 2001 Apr; 102(2):107-14. PubMed ID: 11323020
[TBL] [Abstract][Full Text] [Related]
28. [Diagnostic efficiency of laboratory tests determining the functional status of the endothelium in patients with chronic diffuse liver diseases].
Shchekotova AP; Shchekotov VV; Bulatova IA; Roĭtman AP
Klin Lab Diagn; 2009 Oct; (10):24-6. PubMed ID: 20000110
[TBL] [Abstract][Full Text] [Related]
29. [CHANGES IN LABORATORY MARKERS OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH LIVER CIRRHOSIS].
Sirchak YS
Eksp Klin Gastroenterol; 2016; (7):43-7. PubMed ID: 30284421
[TBL] [Abstract][Full Text] [Related]
30. von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis.
Wu H; Yan S; Wang G; Cui S; Zhang C; Zhu Q
Scand J Gastroenterol; 2015; 50(9):1160-9. PubMed ID: 25877661
[TBL] [Abstract][Full Text] [Related]
31. Association between brain-derived neurotrophic factor and von Willebrand factor levels in patients with stable coronary artery disease.
Jin H; Chen Y; Wang B; Zhu Y; Chen L; Han X; Ma G; Liu N
BMC Cardiovasc Disord; 2018 Feb; 18(1):23. PubMed ID: 29409455
[TBL] [Abstract][Full Text] [Related]
32. Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis.
Lluch P; Torondel B; Medina P; Segarra G; Del Olmo JA; Serra MA; Rodrigo JM
J Hepatol; 2004 Jul; 41(1):55-9. PubMed ID: 15246208
[TBL] [Abstract][Full Text] [Related]
33. Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.
Polatli M; Cakir A; Cildag O; Bolaman AZ; Yenisey C; Yenicerioglu Y
J Thromb Thrombolysis; 2008 Oct; 26(2):97-102. PubMed ID: 17622488
[TBL] [Abstract][Full Text] [Related]
34. The link between circulating markers of endothelial function and proteinuria in patients with primary glomerulonephritis.
Mackinnon B; Deighan CJ; Norrie J; Boulton-Jones JM; Sattar N; Fox JG
Clin Nephrol; 2005 Mar; 63(3):173-80. PubMed ID: 15786817
[TBL] [Abstract][Full Text] [Related]
35. [Changes in plasma von Willebrand factor and nitric oxide levels in patients with pregnancy induced hypertension].
Jin LP; Wang CH; Chen JL
Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):477-9. PubMed ID: 12536509
[TBL] [Abstract][Full Text] [Related]
36. Elevated nitric oxide and 3',5' cyclic guanosine monophosphate levels in patients with alcoholic cirrhosis.
Siqueira C; de Moura MC; Pedro AJ; Rocha P
World J Gastroenterol; 2008 Jan; 14(2):236-42. PubMed ID: 18186561
[TBL] [Abstract][Full Text] [Related]
37. Correlation of nitric oxide and atrial natriuretic peptide changes with altered cGMP homeostasis in liver cirrhosis.
Montoliu C; Kosenko E; Del Olmo JA; Serra MA; Rodrigo JM; Felipo V
Liver Int; 2005 Aug; 25(4):787-95. PubMed ID: 15998430
[TBL] [Abstract][Full Text] [Related]
38. Increased Plasma Nitrite and von Willebrand Factor Indicates Early Diagnosis of Vascular Diseases in Chemotherapy Treated Cancer Patients.
Giri S; Bose JC; Chandrasekar A; Tiwary BK; Gajalakshmi P; Chatterjee S
Cardiovasc Toxicol; 2019 Feb; 19(1):36-47. PubMed ID: 29974375
[TBL] [Abstract][Full Text] [Related]
39. Intermittent pneumatic compression in stable claudicants: effect on hemostasis and endothelial function.
Sutkowska E; Wozniewski M; Gamian A; Gosk-Bierska I; Alexewicz P; Sutkowski K; Wysokinski WE
Int Angiol; 2009 Oct; 28(5):373-9. PubMed ID: 19935591
[TBL] [Abstract][Full Text] [Related]
40. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction.
Jezovnik MK; Poredos P
Int Angiol; 2010 Jun; 29(3):226-31. PubMed ID: 20502419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
